• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

GAP NARROWING BETWEEN FACIAL FILLERS

The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.

Related Videos
Related Content
Pediatric Melanoma in Review: Providing Considerations for Dermatologists
November 22nd 2024

Pediatric Melanoma in Review: Providing Considerations for Dermatologists

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Adapinoid Shows Greater Efficacy and Tolerability Compared to Retinol
November 12th 2024

Adapinoid Shows Greater Efficacy and Tolerability Compared to Retinol

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

The Impact of AR and VR in Enhancing Patient Care and Engagement in Cosmetic Care
November 5th 2024

The Impact of AR and VR in Enhancing Patient Care and Engagement in Cosmetic Care

Off-Treatment Remission Achieved with Dupilumab for Pediatric AD
November 4th 2024

Off-Treatment Remission Achieved with Dupilumab for Pediatric AD

© 2024 MJH Life Sciences

All rights reserved.